Skip to main content

Table 2 Clinical, biological, therapeutic and evolution features of previously reported cases of TCRBCL associated HLH

From: Hemophagocytic lymphohistiocytosis complicating a T-cell rich B-cell lymphoma

Case

Sex

Age

Clinical features

Laboratory findings

Pathology

EBV

Treatment

Outcome

Mitterrer et al. [9]

Female

30

B symptoms, splenomegaly

Moderate pancytopenia, high LDH

Spleen: hemophagocytosis Hepatic nodules: TCRBCL

Reactivated EBV infection serological profile

MOPP-ABV then high dose methotrexate, vincristine and etoposide followed by AHSCT

Sustained CR for 2 years

Devitt et al. [12]

Male

30

Fever, jaundice, B symptoms, splenomegaly, repiratory failure

Hyperferritinemia Pancytopenia Hyperbilirubinemia

Elevated liver enzymes

High LDH

Bone marrow: Hemophagocytosis and lymphomatous infiltration

Negative (in situ hybridization)

HLH 2004, R-EPOCH

CR followed by AHSCT

Aljitawi et Boone [13]

Male

34

Relapse of previously treated TCRBCL

Fever, jaundice, hepatosplenomegaly, ascites

Hyperferritinemia

Pancytopenia

Hyperbilirubinemia

High soluble IL2-R

Bone marrow: Hemphagocytosis, relapsed TCRBCL

NA

Salvage therapy (NA)

Relapse after months and death

Jiang et al. [14]

Male

20

Jaundice

Fatigue

Abdominal disconfort

Fever

Acute hepatitis

Pancytopenia

Hyperferritinemia

High soluble IL2-R

Bone marrow and lymph node: TCRBCL

NA

R-CHOP

CR

Our case

Male

52

B symptoms, splenomegaly

Lymph nodes

Pancytopenia

High LDH

Hyperferritinemia

Bone marrow: hemophagocytosis

Lymph node: TCRBCL

Negative (biopsy and peripheral blood PCR)

R-CHOP

Relapse after 10 months

  1. LDH lacticodeshydrogenase, R-EPOCH Rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicine, CR complete remission, AHSCT autologous hematopoietic stem cell transplantation, TCRBCL T-cell rich B-cell lymphoma, MOPP-ABV mechlorethamine, vincristine, procarbazine, prednisone/doxorubicin, bleomycin, vincristine, PCR polymerase chain reaction